FAQ

What does AOP Orphan stand for?: AOP Orphan developes and distributes mostly ''Orphan'' drugs. These are medicines for diagnosis, prevention or therapy of life threatening or very severe diseases, which are rare and do occurr in no more than 5 of 10.000 persons according to the EU definition.Major pharmaceutical industries are not willing to develope such drugs under the usual market conditions, due to the fact, that expected costs are not met by anticipated revenues which may be generated by the sales of such compounds. Even supportive measures (exclusivity on the market, central registration procedures, research funds etc.) are not sufficient in all cases to remedy the situation.Flexible small enterprises like the AOP Orphan Pharmaceuticals AGdo have significant advantages over multinational companies in such a business environment. Major global players are in principle submitted a profit optimization which may be best met by the introduction of "blockbuster" compounds (annual world wide turnover in excess of 1 billion US$s) which for limited time period warrant the vital competitive advantage.

Category: English